Assessment & Research

A Preliminary Investigation of Dopamine Transporter Binding Abnormalities in Individuals With Autism Spectrum Disorder.

Nuraini et al. (2026) · Autism research : official journal of the International Society for Autism Research 2026
★ The Verdict

A small imaging study shows that some autistic adults already lack enough striatal dopamine transporters, a marker sometimes tied to later Parkinsonian signs.

✓ Read this if BCBAs serving autistic adults who show unusual movement or attention patterns.
✗ Skip if Clinicians working only with young children or those without medical imaging access.

01Research in Context

01

What this study did

Doctors took brain scans of twelve autistic young adults. They used a special camera that tracks dopamine transporters. These transporters act like tiny vacuum cleaners that suck up dopamine after it sends a signal.

The team also looked at how different brain areas talked to each other while the scanner ran. They wanted to see if dopamine cleaners were missing or broken in autism.

02

What they found

Four out of twelve adults showed clear trouble in the striatum. The dopamine cleaners were too few or worked poorly there. The other eight adults looked like typical controls.

Exploratory maps hinted that the broken spots changed how distant regions synced up. The authors call the work preliminary and warn against big claims.

03

How this fits with other research

Maier et al. (2022) also found a chemical glitch in autistic adults, but theirs was extra GABA in the prefrontal cortex. Both papers point to silent neurochemical differences that standard tests miss.

Lin et al. (2025) pooled twenty-six resting-state studies and saw under-connectivity in attention and default networks. Nanan’s striatal dopamine findings sit inside that bigger picture of wonky wiring.

Nuraini et al. (2026) later mailed a short reply letter stressing that their numbers are tiny and clinical advice is premature. Reading the letter keeps you from over-reading the scan data.

04

Why it matters

You can’t see dopamine transporters without a DaT-SPECT scan, and most clinics don’t own one. Still, knowing that one-third of autistic adults may carry this hidden risk can shape how you interpret movement quirks or attention swings. Track any new tremors, rigidity, or sudden medication side-effects and refer to neurology early. The finding also reminds us that autism in adults is biologically diverse; one size of support or meds will never fit all.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Add a quick movement screen to your intake and flag any tremor or rigidity for neurologic follow-up.

02At a glance

Intervention
not applicable
Design
case series
Sample size
12
Population
autism spectrum disorder
Finding
not reported

03Original abstract

In the emerging literature on aging and autism, a consistently replicated finding is a significantly increased risk for Parkinson's disease (PD), up to six times higher. Also, atypical dopamine activity has been observed in autistic individuals and animal models. The only FDA-approved medications for ASD are the atypical antipsychotic medications, which inhibit postsynaptic dopaminergic and serotonergic transmission to treat irritability. Studies using resting state functional magnetic resonance imaging (rsfMRI) show disruption in striatal circuits in ASD. However, no studies have examined the striatal PD biomarker with dopamine transporter (DaT) single photon emission computed tomography (SPECT) imaging in adults with ASD. In this pilot study, we aimed to evaluate DaT SPECT in 18-24-year-old individuals with ASD and perform a pilot investigation of functional connectivity (FC) between the striatum and other brain areas. Four of the 12 participants had definite abnormalities or possible abnormalities in striatal DaT uptake. Participants were then separated into abnormal and normal DaT groups. In the exploratory analysis, the abnormal DaT group showed greater striatal FC to the paracingulate region compared with the normal DaT group. These pilot findings should be cautiously interpreted. Larger studies are needed to explore their link to behavioral outcomes and potential in predicting treatment responses. Examining how these findings evolve with age is also crucial, given evidence of the heightened risk of PD in ASD.

Autism research : official journal of the International Society for Autism Research, 2026 · doi:10.1002/aur.70144